SlideShare a Scribd company logo
APROACH TO DIAGNOSIS
OF PLEURAL EFFUSION
DR. AMIT KALNE
DEFINITION
• Pleural effusion results from fluid accumulating in
the potential space between the visceral and
parietal pleura When there is an imbalance
between formation and absorption in various
disease states , in response to injury ,
inflammation, or both locally and systematically .
PLEURAL FLUID FORMATION
• Pleural fluid that normally enter the pleural space
originates in the capillaries in parietal pleura
•Pleural fluid absorbed by lymphatic vesseles in the
parietal pleura by means of stoma in the parietal
pleura
•Rate of formation equals the rate of absorption
which is about 0.01 – 0.02 ml/kg per hr.
• Lymphatics have the capacity to absorb 20 times
more than what is Produced
• Fluid can also enter the pleural cavity from
interstitial spaces of lung through visceral pleura
PATHOGENESIS OF PLEURAL EFFUSION
•Pleural fluid accumulates when the rate of pleural
fluid formation exceeds the rate of pleural fluid
reabsorption
• Normally 0.01ml/kg /hr of fluid constantly enters
the pleural space from the capillaries in the parietal
pleura
•Almost all the fluid removed by the lymphatic in the
parietal pleura which have the capacity to remove
TYPES OF PLEURAL EFFUSION
•TRANSDUATIVE
•EXUDATIVE
SEPARATION OF TRANSDUATIVE FROM
EXUDATIVE EFFUSION (LIGHT S CRITERIA)
•Pleural fluid protein-to-serum protein ratio more
than 0.5
•Pleural fluid LDH-to-serum LDH ratio more than 0.6
•Pleural fluid LDH level greater than two third the
upper limit of normal serum level
SERUM-EFFUSION ALBUMIN GRADIENT (SAG)
• In general Light’s criteria occasionally misidentify a
transudative effusion as an exudative effusion as in
cardiac failure with diuretic therapy
• Clinically if a patient should have a transudative
effusion, but meets Light’s criteria for an exudative
effusion, measure serum - pleural fluid albumin
gradient,or measure the serum-pleural protein
gradient
Serum- effusion albumin gradient of more
than 1.2 g/dl transudative
Serum-effusion protein gradient more
than 3.1g/dl transudative
An alternative approach to measure NT
pro BNP level(>1500pg/ml)
OTHER TESTS
• SPECIFIC GRAVITY-used in past to separate transudative from
exudative. A specific gravity of 1.015 corresponds to protien
contents of 3 g /dl, and this value was used to separate from
exudative from transudative
• NT PRO BNP-the level of NT pro BNP in the pleural fluid are used
to establish the diagnosis of CHF(>1500pg/ml).
GLUCOSE MEASURMENT-low pleural
glucose level (<60mg/dl)indicates-
parapneumonic effusion, malignant
disease, rheumatoid disease,
tuberculus pleuritis. presence of low
glucose level is poor prognostic sign in
parapneumonic effusion
AMYLASE DETERMINATION-pleural fluid
amylase level above upper normal limit
(200iu/ml)for serum indicates the patient
has one of three problem1
1 pancreatic disease
2 malignant tumor
3 esophageal rupture
Amylase in
malignant pleural effusion and esophageal
rupture is of salivary type.
LDH MEASUREMENT
LDH is reliable indicator of the degree of pleural
inflammation, higher the LDH ,more inflamed the
pleural surface
most of the patient who meet the criteria of
exudative pleural effusion with LDH but not with
protein level have either parapneumonic effusion
or malignant pleural disease
LDH isoenzyme determination in only one
situation when there is bloody pleural effusion in
a patient who is clinically thought to have
transudative pleural effusion. if LDH is in
exudative range, and the protein in transudative
range ,the demonstration the most of LDH is
LDH1 indicates that the increase in the LDH is due
to blood
PH -If the pleural fluid pH is less than 7.2 it
means that the patient has 1 of 10 conditions
1 .Complicated parapneumonic effusion
2. Esophageal rupture
3 . Rheumatoid pleuritis
4. Tuberculous pleuritis
5. Malignant pleural disease
6. Hemothorax
7. Systemic acidosis
8. Paragonimiasis
9 . Lupus pleuritis
10. Urinothorax
In general pleural fluid with low pH also
have a low glucose and high LDH level. if
the laboratory report a low pH with normal
glucose and low LDH level ,the pH
measurement probably a laboratory error
Total and Differential Cell Counts
Predominance of neutrophils in the fluid
>50% indicates that an acute process is
affecting the pleura.
IL8 is primary chemotaxins for neutrophil in
the pleural space.
Common causes include
• parapneumonic effusions (81 percent),
• effusions secondary to pulmonary
embolus (80 percent), and
• those secondary to pancreatitis(80
percent).
Mononuclear cells like small
lymphocytes >50% indicates a chronic
process.
• cancer or tuberculous pleuritis,
• effusions after coronary-artery bypass
surgery,
Pleural-fluid eosinophilia >10%
• IL5(CD4 CELLS) and eotaxin 3.
• caused in about two thirds of cases by
blood or air in the pleural space.
• uncommon in cancer or tuberculosis,
unless the patient has undergone repeated
thoracentesis
• Other causes reactions to drugs
(dantrolene, bromocriptine, or
nitrofurantoin), exposure to asbestos,
paragonimiasis, and the Churg–Strauss
syndrome
MARKERS OF TUBERCULOSIS
• ADA MEASUREMENT-ADA is enzyme that catalyze the
conversion of adenosine to inosine. cutoff level is 40u/l.
• Two main disease that cause an elevated ADA in addition
to tuberculosis are rheumatoid pleuritis and empyema.
• If the diagnostic criteria for tuberculous pleuritis patient
also include a pleural fluid lymphocyte to neutrophil ratio
greater than 0.75 the specificity of the test is increased.
• ADA has 2 isoenzymes ADA1 and
ADA2.ADA1 is produced by lymphocyte,
neutrophil , monocyte and macrophage.in
contrast ADA 2 exist only in monocyte and
macrophages. the increase in ADA activity in
tuberculous pleuritis is mainly due to ADA2
.(origin of pleural fluid ADA is probably
pleural tissue).ADA1 to ADA2 ratio of less
than 0.42 increased the accuracy.
Markers of Tuberculosis
INTERFERON-GAMMA
• Produced by cd4 lymphocyte
• levels above 140pg/ml/3.7 U/ml are very
suggestive of TB
• Elevated whether or not the patient is
immunosuppressed
• Is more expensive than ADA
• Sensitivity and specificity for interferon-
gamma is 96%
C REACTIVE PROTIEN
• Patient with tuberculous pleuritis tend to
have higher pleural fluid level of C reactive
protein than do patient with other
lymphocytic pleural effusion. Level >50
mg/dl high specificity for tuberculosis. but it
doesn’t appear to be as accurate as ADA
level
• Lysozyme-the level of lysozyme in pleural
fluid tend to be higher in pleura fluid from
patient with tuberculous pleuritis than in
other types of exudate.
• Procalcitonin-higher mean level with
empyema followed by parapneumonic
effusion and then tuberculous pleurisy and
malignant pleural effusion
• If eosinophils are found in pleural fluid in
significant number(>10 %)one can virtually
exclude the diagnosis of tuberculous
pleuritis unless the patient has
pneumothorax or had a previous
thoracentesis
• Pleural fluid from patient with TB rarely
contains more than 5% mesothelial cells.it
has been suggested that hiv infected with
TB have significant number of mesothelial
cells.
PCR FOR DIAGNOSIS OF TUBERCULOUS
PLEURITIS
• With PCR one can identify the presence of
DNA from M. tuberculosis in the pleural
fluid
• PCR was not superior to an ADA level >45
• In general PCR in pleural fluid has been
less sensitive than PCR of other material
• Sensitivity and specificity of PCR for
diagnosis of tuberculus pleuritis is 81% and
100% respectively
Pleural biopsy in tuberculous pleuritis
• demonstration of granuloma in the parietal
pleura suggests tuberculous pleuritis; caseous
necrosis and AFB need not be demonstrated
• More than 95 per of patient with granulomatous
pleuritis have TB
• ADA which are at least as sensitive in
diagnosing tuberculous pleuritis as needle biopsy
of the pleura, resulted in decrease use of the
needle biopsy of pleura
• Indication of needle biopsy of pleura
1. Tuberculous pleuritis
2. malignancy
Smears and Cultures
• for nonimmunosuppressd patients routine smears
of the pleural fluid for mycobacteria are not indicated
because they are usually negative, unless the patient
has tuberculous empyema
• Pleural fluid from patients with undiagnosed
exudative pleural effusion should be cultured for
bacteria, mycobacteria and fungi.
• Fluid should be inoculated directly into blood
culture media at bedside because the number
positive culture will increase with this methods
• For mycobacteria culture use of BACTEC system
with bedside inoculation provides higher yields and
faster result.
• The sensitivities of pleural fluid culture and AFB
smear were 42% and 1%, respectively
RADIOGRAPHIC EXAMINATION
• the fluid first gravitates at the base of hemithorax and come to
rest between inferior surface of the lung and diaphragm,
particularly posteriorly where the pleural sinus is most posteriorly
• Subpulmonic or infrapulmonary effusion
1. At times for unknown reason substantial amount of pleural fluid
(>1000ml)can be present may remain in an infrapulmonary
location without spilling into costophrenic sulci or extending up
the chest wall. such pleural fluid accumulation are called
subpulmonic or infrapulmonic effusion
2. presence of one or more of these characteristics
serve as an indication of decubitus examination
a)apparent elevation of one or both diaphragm
b)apex of apparent diaphragm is more lateral than
usual c)slope of apparent diaphragm is more sharply
towards the costophrenic angle
d)normally the top of the left diaphragm on the PA
view is less than 2 cm above stomach air bubble .a
separation greater than 2 cm suggests subpulmonic
effusion
e)lower lobe vessels may not be seen below the
RADIOGRAPHIC EXAMINATION
• 75 mL-subpulmonic space without spill over, can
obliterate the posterior costophrenic sulcus,
• 175 mL is necessary to obscure the lateral
costophrenic sulcus on an upright chest radiograph
• 500 mL will obscure the diaphragmatic contour on
an upright chest radiograph;
• 1000 ml of effusion reaches the level of the fourth
anterior rib,
• On decubitus radiographs and CT scans, less than 10
mL.
RADIOGRAPHIC EXAMINATION
Based on the decubitus films
• small effusions are thinner than 1.5 cm,
moderate effusions are 1.5 to 4.5 cm thick, and
large effusions exceed 4.5 cm.
• Effusions thicker than one cm are usually
large enough for sampling by thoracentesis,
since at least 200 mL of liquid are already
present
ROLE OF USG
1.Determining whether pleural fluid is present
2. Identification of appropriate location for an
attempted thoracentesis ,pleural biopsy or chest
tube placement
3. Identification of pleural fluid loculations
4. Distinction of pleural fluid from pleural thickening
5. Quantitation of amount of pleural fluid
6. Differentiation of pyopneumothorax from lung
abscess
7. Assessment as to whether a pleurodesis is present
Role of CT scan
• Visualization of underlying lung
parenchymal processes that are obscured on
chest radiographs by large pleural effusions
• Distinguishing empyema from lung abscess
• Help in distinguishing benign from
malignant pleural effusion-pleural nodularity,
mediastinal pleura involvement, pleural
thickening greater than 1 cm.
Loculated pleural effusion
• Encapsulated by adhesion anywhere
parietal and visceral pleura or in the interlobar
fissure
• It occurs most commonly with intense pleural
inflammation such as empyema hemothorax,or
tuberculous pleuritis.
• A definitive diagnosis of loculated pleural
effusion is best established by ultrasound
Loculated effusion in fissure
1simulate a mass in PA radiograph.
2Most frequently seen in patient with CHF.
3vanishing tumor or pseudotumor.
4the most common location is right horizontal
fissure
APPROACH TO THE PATIENT
• If thickness of fluid greater than 10 mm
decubitus radiograph, USG, CT scan, then
we should performing diagnostic
thoracentesis
• In CHF diagnostic thoracentesis is
performed if
1The effusion are not bilateral
2. Patient has pleuritic chest pain
3. Patient is febrile
APPEARANCE OF PLEURAL FLUID
• Bloody- Cancer>PE>Trauma>Pneumonia
• Turbid- due to cells or debris or a high lipid level-
Empyema
Chylothorax
pseudochylothorax
• Putrid odour- Anaerobic infection.
• Ammonia odour- urinothorax
Bloody : Hematocrit compared to the blood :
• <1% is not significant
• 1-20% indicates either cancer, PE or trauma
• >50% indicates hemothorax.
Centrifuging turbid or milky pleural fluid will distinguish between
empyema and lipid effusions.
• If the supernatant is clear then the turbid fluid was due to
empyema
• If it is still turbid
-chylothorax OR
-pseudochylothorax
- Check TG - >110mg/dl – chylothorax If TG<50mg/dl and
cholesterol>250 - pseudochylothorax
PARAPNEUMONIC EFFUSION AND EMPYEMA
• Any pleural effusion associated with bacterial
pneumonia ,lung abscess, or bronchiectasis is a
parapneumonic effusion
• An empyema is pus in pleural space
• Complicated parapneumonic effusion-refer to
those effusion that do not resolve without
therapeutic thoracentesis or tube thoracostomy
Bad prognostic factor for parapneumonic effusion
and empyema
1Pus present in pleural space
2. Gram stain of pleural fluid is positive
3. Pleural fluid glucose below 40mg/dl
4. Pleural fluid culture positive
5. Pleural fluid ph<7
6. Pleural fluid LDH >3times upper normal limit for
serum
7. Pleural fluid loculated These factors indicating
likely need for a procedure more invasive than a
Pleural effusion related to metastatic malignancies
• 2nd most common cause of exudative pleural
effusion after parapneumonic effusion
• Leading cause of exudative pleural effusion
to thoracentesis
• Common causes of malignant pleural effusion
1.Lung carcinoma
2. Breast carcinoma
3. Lymphoma and leukemia
4. Ovarian carcinoma 5. sarcoma
Pleural fluid in malignant pleural effusion
• Almost exudative
• Most pleural effusion that meet exudative criteria by the
LDH but not by protein level are malignant pleural
• bloody pleural effusion
• Low pleural glucose level in malignant pleural effusion
indicates high tumor burden in pleural space
• Approx. one third of patient with malignant disease have
a low PH level. low pleural PH also tend to have a low
pleural glucose level. they have greater tumor burden, are
more likely to have positive pleural fluid cytology and
pleural biopsy.
Diagnosis of malignant pleural effusion
• Cytology- is a fast, efficient, and minimally invasive
establishes the diagnosis in more than 70 percent of
of metastatic adenocarcinoma less efficient in the
diagnosis of a mesothelioma squamous cell carcinoma,
lymphoma or a sarcoma.
• Immunohistochemical tests-metastatic adenocarcinoma
tend to stain positive with CEA,MOC31,BG8,TTF1.
malignant mesothelial cells and benign mesothelial cells
stain positive with calretinin,keratin5/6,podoplanin,wt1.
• Tumor markers in pleural fluid-CEA,CA,NSE,SCC
antigen, cytokeratin 19 fragment,
• Blood marker of mesothelioma-soluble mesothelin
related protien(smrp),osteopontin,megakaryocye
potentiating factor(MPF)
• If cytology is negative – go for thoracoscopy
INVASIVE APROACH
•Pleural biopsy
•Blind
•thoracoscopy
THANK YOU

More Related Content

What's hot

Acute Cardiogenic Pulmonary Oedema - (ACPO)
Acute Cardiogenic Pulmonary Oedema - (ACPO)Acute Cardiogenic Pulmonary Oedema - (ACPO)
Acute Cardiogenic Pulmonary Oedema - (ACPO)
steveclaydon1970
 
Pleural disease (Pleural effusion & Empyme)
Pleural disease (Pleural effusion & Empyme)Pleural disease (Pleural effusion & Empyme)
Pleural disease (Pleural effusion & Empyme)
Thulasiraman Magendiran
 
Pulmonary edema
Pulmonary edemaPulmonary edema
Pulmonary edema
Rodas Temesgen
 
Syndrome of inappropriate anti diuretic hormone release (SIADH)
Syndrome of inappropriate anti diuretic hormone release (SIADH)Syndrome of inappropriate anti diuretic hormone release (SIADH)
Syndrome of inappropriate anti diuretic hormone release (SIADH)
Mosese HULKSTAH Tuapati JNR
 
Acute heart failure [MBBS]
Acute heart failure [MBBS]Acute heart failure [MBBS]
Acute heart failure [MBBS]
Anwar Kamal
 
Pulmonary artery Hypertension
Pulmonary artery HypertensionPulmonary artery Hypertension
Pulmonary artery Hypertension
Rikin Hasnani
 
Lec 3 management of acute pulmonary oedema for mohs
Lec 3 management of acute pulmonary oedema for mohsLec 3 management of acute pulmonary oedema for mohs
Lec 3 management of acute pulmonary oedema for mohs
EhealthMoHS
 
Ventilator Graphics
Ventilator GraphicsVentilator Graphics
Ventilator Graphics
Smruti Patanaik
 
(Pneumothorax
(Pneumothorax(Pneumothorax
(Pneumothorax
Atiya Parveen
 
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & ManagementDisorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Abdullah Ansari
 
Chylothorax
ChylothoraxChylothorax
Chylothorax
Vijay Anand
 
Ventilator graphics
Ventilator graphicsVentilator graphics
Ventilator graphics
Prithvi Raj S J
 
ACUTE GI BLEEDING
 ACUTE GI BLEEDING ACUTE GI BLEEDING
ACUTE GI BLEEDING
Siraj Shiferaw
 
Hepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku JosephHepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku Joseph
Dr.Tinku Joseph
 

What's hot (20)

Acute Cardiogenic Pulmonary Oedema - (ACPO)
Acute Cardiogenic Pulmonary Oedema - (ACPO)Acute Cardiogenic Pulmonary Oedema - (ACPO)
Acute Cardiogenic Pulmonary Oedema - (ACPO)
 
Pleural disease (Pleural effusion & Empyme)
Pleural disease (Pleural effusion & Empyme)Pleural disease (Pleural effusion & Empyme)
Pleural disease (Pleural effusion & Empyme)
 
Pulmonary edema
Pulmonary edemaPulmonary edema
Pulmonary edema
 
Syndrome of inappropriate anti diuretic hormone release (SIADH)
Syndrome of inappropriate anti diuretic hormone release (SIADH)Syndrome of inappropriate anti diuretic hormone release (SIADH)
Syndrome of inappropriate anti diuretic hormone release (SIADH)
 
Acute heart failure [MBBS]
Acute heart failure [MBBS]Acute heart failure [MBBS]
Acute heart failure [MBBS]
 
Pulmonary artery Hypertension
Pulmonary artery HypertensionPulmonary artery Hypertension
Pulmonary artery Hypertension
 
upper gi bleed - lecture 1
 upper gi bleed - lecture 1 upper gi bleed - lecture 1
upper gi bleed - lecture 1
 
ARDS
ARDS ARDS
ARDS
 
Ards new
Ards newArds new
Ards new
 
Lec 3 management of acute pulmonary oedema for mohs
Lec 3 management of acute pulmonary oedema for mohsLec 3 management of acute pulmonary oedema for mohs
Lec 3 management of acute pulmonary oedema for mohs
 
ARDS
ARDSARDS
ARDS
 
Ventilator Graphics
Ventilator GraphicsVentilator Graphics
Ventilator Graphics
 
Pediatric Shock Ii
Pediatric  Shock IiPediatric  Shock Ii
Pediatric Shock Ii
 
(Pneumothorax
(Pneumothorax(Pneumothorax
(Pneumothorax
 
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & ManagementDisorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
Disorders of Sodium (Hyponatremia& Hypernatremia) : Approach & Management
 
Chylothorax
ChylothoraxChylothorax
Chylothorax
 
Cor pulmonale
Cor pulmonaleCor pulmonale
Cor pulmonale
 
Ventilator graphics
Ventilator graphicsVentilator graphics
Ventilator graphics
 
ACUTE GI BLEEDING
 ACUTE GI BLEEDING ACUTE GI BLEEDING
ACUTE GI BLEEDING
 
Hepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku JosephHepatopulmonary Syndrome By Dr.Tinku Joseph
Hepatopulmonary Syndrome By Dr.Tinku Joseph
 

Similar to Aproach To Diagnosis of Pleural Effusion

MALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxMALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptx
JibinJames35
 
Pleural Effusion for Undergraduates
Pleural Effusion for UndergraduatesPleural Effusion for Undergraduates
Pleural Effusion for Undergraduates
Sesha Sai
 
Approaches to pleural effusion
Approaches to pleural effusionApproaches to pleural effusion
Approaches to pleural effusion
Dr Slayer
 
PARA PNEUMONIC EFFUSION
PARA PNEUMONIC EFFUSIONPARA PNEUMONIC EFFUSION
PARA PNEUMONIC EFFUSION
Dr.Aslam calicut
 
ppe-130802100208-phpapp02 (1).pdf
ppe-130802100208-phpapp02 (1).pdfppe-130802100208-phpapp02 (1).pdf
ppe-130802100208-phpapp02 (1).pdf
SENTHILKUMARANVISHNU
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
Eyad Miskawi
 
Pleural effusion
Pleural effusion Pleural effusion
Pleural effusion
Ujaas Dawar
 
Pleural effusion in children
Pleural effusion in childrenPleural effusion in children
Pleural effusion in children
ravindrabn4
 
Malignant pleural effusion
Malignant pleural effusion Malignant pleural effusion
Malignant pleural effusion
Dileep Benji
 
approachtopleuraleffusion-140205151929-phpapp01.pdf
approachtopleuraleffusion-140205151929-phpapp01.pdfapproachtopleuraleffusion-140205151929-phpapp01.pdf
approachtopleuraleffusion-140205151929-phpapp01.pdf
NellyPhiri5
 
Pleural effusion dr magdi sasi
Pleural  effusion dr magdi sasiPleural  effusion dr magdi sasi
Pleural effusion dr magdi sasi
cardilogy
 
Paediatric empyema case presentation
Paediatric empyema case presentationPaediatric empyema case presentation
Paediatric empyema case presentation
Asia Noureen
 
Pleural Effusion lecture
Pleural Effusion lecturePleural Effusion lecture
Pleural Effusion lecture
BasilQuran
 
Diagnostic value of pleural effusion
Diagnostic value of pleural effusionDiagnostic value of pleural effusion
Diagnostic value of pleural effusion
Sarfraz Saleemi
 
KMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx ggggggggggggggKMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx gggggggggggggg
ShanuSoni7
 
L5 pleural effusion
L5 pleural effusionL5 pleural effusion
L5 pleural effusion
bilal natiq
 
pleuraleffusion.pptx
pleuraleffusion.pptxpleuraleffusion.pptx
pleuraleffusion.pptx
ThenarasanG
 
Approach to pleural effusion
Approach to pleural effusionApproach to pleural effusion
Approach to pleural effusion
Muhammad Asim Rana
 
Management of Parapneumonic Effusion and Empyema
Management of Parapneumonic Effusion and EmpyemaManagement of Parapneumonic Effusion and Empyema
Management of Parapneumonic Effusion and Empyema
Dileep Benji
 

Similar to Aproach To Diagnosis of Pleural Effusion (20)

MALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxMALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptx
 
Pleural Effusion for Undergraduates
Pleural Effusion for UndergraduatesPleural Effusion for Undergraduates
Pleural Effusion for Undergraduates
 
Approaches to pleural effusion
Approaches to pleural effusionApproaches to pleural effusion
Approaches to pleural effusion
 
PARA PNEUMONIC EFFUSION
PARA PNEUMONIC EFFUSIONPARA PNEUMONIC EFFUSION
PARA PNEUMONIC EFFUSION
 
ppe-130802100208-phpapp02 (1).pdf
ppe-130802100208-phpapp02 (1).pdfppe-130802100208-phpapp02 (1).pdf
ppe-130802100208-phpapp02 (1).pdf
 
Pleural effusion
Pleural effusionPleural effusion
Pleural effusion
 
Pleural effusion
Pleural effusion Pleural effusion
Pleural effusion
 
Pleural effusion in children
Pleural effusion in childrenPleural effusion in children
Pleural effusion in children
 
Malignant pleural effusion
Malignant pleural effusion Malignant pleural effusion
Malignant pleural effusion
 
approachtopleuraleffusion-140205151929-phpapp01.pdf
approachtopleuraleffusion-140205151929-phpapp01.pdfapproachtopleuraleffusion-140205151929-phpapp01.pdf
approachtopleuraleffusion-140205151929-phpapp01.pdf
 
Pleural effusion dr magdi sasi
Pleural  effusion dr magdi sasiPleural  effusion dr magdi sasi
Pleural effusion dr magdi sasi
 
Paediatric empyema case presentation
Paediatric empyema case presentationPaediatric empyema case presentation
Paediatric empyema case presentation
 
Pleural Effusion lecture
Pleural Effusion lecturePleural Effusion lecture
Pleural Effusion lecture
 
Inflammation(3)
Inflammation(3)Inflammation(3)
Inflammation(3)
 
Diagnostic value of pleural effusion
Diagnostic value of pleural effusionDiagnostic value of pleural effusion
Diagnostic value of pleural effusion
 
KMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx ggggggggggggggKMC Pleural effusion.pptx gggggggggggggg
KMC Pleural effusion.pptx gggggggggggggg
 
L5 pleural effusion
L5 pleural effusionL5 pleural effusion
L5 pleural effusion
 
pleuraleffusion.pptx
pleuraleffusion.pptxpleuraleffusion.pptx
pleuraleffusion.pptx
 
Approach to pleural effusion
Approach to pleural effusionApproach to pleural effusion
Approach to pleural effusion
 
Management of Parapneumonic Effusion and Empyema
Management of Parapneumonic Effusion and EmpyemaManagement of Parapneumonic Effusion and Empyema
Management of Parapneumonic Effusion and Empyema
 

Recently uploaded

Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 

Recently uploaded (20)

Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 

Aproach To Diagnosis of Pleural Effusion

  • 1. APROACH TO DIAGNOSIS OF PLEURAL EFFUSION DR. AMIT KALNE
  • 2. DEFINITION • Pleural effusion results from fluid accumulating in the potential space between the visceral and parietal pleura When there is an imbalance between formation and absorption in various disease states , in response to injury , inflammation, or both locally and systematically .
  • 3. PLEURAL FLUID FORMATION • Pleural fluid that normally enter the pleural space originates in the capillaries in parietal pleura •Pleural fluid absorbed by lymphatic vesseles in the parietal pleura by means of stoma in the parietal pleura
  • 4. •Rate of formation equals the rate of absorption which is about 0.01 – 0.02 ml/kg per hr. • Lymphatics have the capacity to absorb 20 times more than what is Produced • Fluid can also enter the pleural cavity from interstitial spaces of lung through visceral pleura
  • 5. PATHOGENESIS OF PLEURAL EFFUSION •Pleural fluid accumulates when the rate of pleural fluid formation exceeds the rate of pleural fluid reabsorption • Normally 0.01ml/kg /hr of fluid constantly enters the pleural space from the capillaries in the parietal pleura •Almost all the fluid removed by the lymphatic in the parietal pleura which have the capacity to remove
  • 6.
  • 7. TYPES OF PLEURAL EFFUSION •TRANSDUATIVE •EXUDATIVE
  • 8. SEPARATION OF TRANSDUATIVE FROM EXUDATIVE EFFUSION (LIGHT S CRITERIA) •Pleural fluid protein-to-serum protein ratio more than 0.5 •Pleural fluid LDH-to-serum LDH ratio more than 0.6 •Pleural fluid LDH level greater than two third the upper limit of normal serum level
  • 9. SERUM-EFFUSION ALBUMIN GRADIENT (SAG) • In general Light’s criteria occasionally misidentify a transudative effusion as an exudative effusion as in cardiac failure with diuretic therapy • Clinically if a patient should have a transudative effusion, but meets Light’s criteria for an exudative effusion, measure serum - pleural fluid albumin gradient,or measure the serum-pleural protein gradient
  • 10. Serum- effusion albumin gradient of more than 1.2 g/dl transudative Serum-effusion protein gradient more than 3.1g/dl transudative An alternative approach to measure NT pro BNP level(>1500pg/ml)
  • 11. OTHER TESTS • SPECIFIC GRAVITY-used in past to separate transudative from exudative. A specific gravity of 1.015 corresponds to protien contents of 3 g /dl, and this value was used to separate from exudative from transudative • NT PRO BNP-the level of NT pro BNP in the pleural fluid are used to establish the diagnosis of CHF(>1500pg/ml).
  • 12. GLUCOSE MEASURMENT-low pleural glucose level (<60mg/dl)indicates- parapneumonic effusion, malignant disease, rheumatoid disease, tuberculus pleuritis. presence of low glucose level is poor prognostic sign in parapneumonic effusion
  • 13. AMYLASE DETERMINATION-pleural fluid amylase level above upper normal limit (200iu/ml)for serum indicates the patient has one of three problem1 1 pancreatic disease 2 malignant tumor 3 esophageal rupture Amylase in malignant pleural effusion and esophageal rupture is of salivary type.
  • 14. LDH MEASUREMENT LDH is reliable indicator of the degree of pleural inflammation, higher the LDH ,more inflamed the pleural surface most of the patient who meet the criteria of exudative pleural effusion with LDH but not with protein level have either parapneumonic effusion or malignant pleural disease
  • 15. LDH isoenzyme determination in only one situation when there is bloody pleural effusion in a patient who is clinically thought to have transudative pleural effusion. if LDH is in exudative range, and the protein in transudative range ,the demonstration the most of LDH is LDH1 indicates that the increase in the LDH is due to blood
  • 16. PH -If the pleural fluid pH is less than 7.2 it means that the patient has 1 of 10 conditions 1 .Complicated parapneumonic effusion 2. Esophageal rupture 3 . Rheumatoid pleuritis 4. Tuberculous pleuritis 5. Malignant pleural disease 6. Hemothorax 7. Systemic acidosis 8. Paragonimiasis 9 . Lupus pleuritis 10. Urinothorax
  • 17. In general pleural fluid with low pH also have a low glucose and high LDH level. if the laboratory report a low pH with normal glucose and low LDH level ,the pH measurement probably a laboratory error
  • 18. Total and Differential Cell Counts Predominance of neutrophils in the fluid >50% indicates that an acute process is affecting the pleura. IL8 is primary chemotaxins for neutrophil in the pleural space. Common causes include • parapneumonic effusions (81 percent), • effusions secondary to pulmonary embolus (80 percent), and • those secondary to pancreatitis(80 percent).
  • 19. Mononuclear cells like small lymphocytes >50% indicates a chronic process. • cancer or tuberculous pleuritis, • effusions after coronary-artery bypass surgery,
  • 20. Pleural-fluid eosinophilia >10% • IL5(CD4 CELLS) and eotaxin 3. • caused in about two thirds of cases by blood or air in the pleural space. • uncommon in cancer or tuberculosis, unless the patient has undergone repeated thoracentesis • Other causes reactions to drugs (dantrolene, bromocriptine, or nitrofurantoin), exposure to asbestos, paragonimiasis, and the Churg–Strauss syndrome
  • 21. MARKERS OF TUBERCULOSIS • ADA MEASUREMENT-ADA is enzyme that catalyze the conversion of adenosine to inosine. cutoff level is 40u/l. • Two main disease that cause an elevated ADA in addition to tuberculosis are rheumatoid pleuritis and empyema. • If the diagnostic criteria for tuberculous pleuritis patient also include a pleural fluid lymphocyte to neutrophil ratio greater than 0.75 the specificity of the test is increased.
  • 22. • ADA has 2 isoenzymes ADA1 and ADA2.ADA1 is produced by lymphocyte, neutrophil , monocyte and macrophage.in contrast ADA 2 exist only in monocyte and macrophages. the increase in ADA activity in tuberculous pleuritis is mainly due to ADA2 .(origin of pleural fluid ADA is probably pleural tissue).ADA1 to ADA2 ratio of less than 0.42 increased the accuracy.
  • 23. Markers of Tuberculosis INTERFERON-GAMMA • Produced by cd4 lymphocyte • levels above 140pg/ml/3.7 U/ml are very suggestive of TB • Elevated whether or not the patient is immunosuppressed • Is more expensive than ADA • Sensitivity and specificity for interferon- gamma is 96%
  • 24. C REACTIVE PROTIEN • Patient with tuberculous pleuritis tend to have higher pleural fluid level of C reactive protein than do patient with other lymphocytic pleural effusion. Level >50 mg/dl high specificity for tuberculosis. but it doesn’t appear to be as accurate as ADA level
  • 25. • Lysozyme-the level of lysozyme in pleural fluid tend to be higher in pleura fluid from patient with tuberculous pleuritis than in other types of exudate. • Procalcitonin-higher mean level with empyema followed by parapneumonic effusion and then tuberculous pleurisy and malignant pleural effusion
  • 26. • If eosinophils are found in pleural fluid in significant number(>10 %)one can virtually exclude the diagnosis of tuberculous pleuritis unless the patient has pneumothorax or had a previous thoracentesis • Pleural fluid from patient with TB rarely contains more than 5% mesothelial cells.it has been suggested that hiv infected with TB have significant number of mesothelial cells.
  • 27. PCR FOR DIAGNOSIS OF TUBERCULOUS PLEURITIS • With PCR one can identify the presence of DNA from M. tuberculosis in the pleural fluid • PCR was not superior to an ADA level >45 • In general PCR in pleural fluid has been less sensitive than PCR of other material • Sensitivity and specificity of PCR for diagnosis of tuberculus pleuritis is 81% and 100% respectively
  • 28. Pleural biopsy in tuberculous pleuritis • demonstration of granuloma in the parietal pleura suggests tuberculous pleuritis; caseous necrosis and AFB need not be demonstrated • More than 95 per of patient with granulomatous pleuritis have TB • ADA which are at least as sensitive in diagnosing tuberculous pleuritis as needle biopsy of the pleura, resulted in decrease use of the needle biopsy of pleura • Indication of needle biopsy of pleura 1. Tuberculous pleuritis 2. malignancy
  • 29. Smears and Cultures • for nonimmunosuppressd patients routine smears of the pleural fluid for mycobacteria are not indicated because they are usually negative, unless the patient has tuberculous empyema • Pleural fluid from patients with undiagnosed exudative pleural effusion should be cultured for bacteria, mycobacteria and fungi.
  • 30. • Fluid should be inoculated directly into blood culture media at bedside because the number positive culture will increase with this methods • For mycobacteria culture use of BACTEC system with bedside inoculation provides higher yields and faster result. • The sensitivities of pleural fluid culture and AFB smear were 42% and 1%, respectively
  • 31. RADIOGRAPHIC EXAMINATION • the fluid first gravitates at the base of hemithorax and come to rest between inferior surface of the lung and diaphragm, particularly posteriorly where the pleural sinus is most posteriorly • Subpulmonic or infrapulmonary effusion 1. At times for unknown reason substantial amount of pleural fluid (>1000ml)can be present may remain in an infrapulmonary location without spilling into costophrenic sulci or extending up the chest wall. such pleural fluid accumulation are called subpulmonic or infrapulmonic effusion
  • 32. 2. presence of one or more of these characteristics serve as an indication of decubitus examination a)apparent elevation of one or both diaphragm b)apex of apparent diaphragm is more lateral than usual c)slope of apparent diaphragm is more sharply towards the costophrenic angle d)normally the top of the left diaphragm on the PA view is less than 2 cm above stomach air bubble .a separation greater than 2 cm suggests subpulmonic effusion e)lower lobe vessels may not be seen below the
  • 33.
  • 34. RADIOGRAPHIC EXAMINATION • 75 mL-subpulmonic space without spill over, can obliterate the posterior costophrenic sulcus, • 175 mL is necessary to obscure the lateral costophrenic sulcus on an upright chest radiograph • 500 mL will obscure the diaphragmatic contour on an upright chest radiograph; • 1000 ml of effusion reaches the level of the fourth anterior rib, • On decubitus radiographs and CT scans, less than 10 mL.
  • 35. RADIOGRAPHIC EXAMINATION Based on the decubitus films • small effusions are thinner than 1.5 cm, moderate effusions are 1.5 to 4.5 cm thick, and large effusions exceed 4.5 cm. • Effusions thicker than one cm are usually large enough for sampling by thoracentesis, since at least 200 mL of liquid are already present
  • 36. ROLE OF USG 1.Determining whether pleural fluid is present 2. Identification of appropriate location for an attempted thoracentesis ,pleural biopsy or chest tube placement 3. Identification of pleural fluid loculations 4. Distinction of pleural fluid from pleural thickening 5. Quantitation of amount of pleural fluid 6. Differentiation of pyopneumothorax from lung abscess 7. Assessment as to whether a pleurodesis is present
  • 37. Role of CT scan • Visualization of underlying lung parenchymal processes that are obscured on chest radiographs by large pleural effusions • Distinguishing empyema from lung abscess • Help in distinguishing benign from malignant pleural effusion-pleural nodularity, mediastinal pleura involvement, pleural thickening greater than 1 cm.
  • 38.
  • 39. Loculated pleural effusion • Encapsulated by adhesion anywhere parietal and visceral pleura or in the interlobar fissure • It occurs most commonly with intense pleural inflammation such as empyema hemothorax,or tuberculous pleuritis. • A definitive diagnosis of loculated pleural effusion is best established by ultrasound
  • 40. Loculated effusion in fissure 1simulate a mass in PA radiograph. 2Most frequently seen in patient with CHF. 3vanishing tumor or pseudotumor. 4the most common location is right horizontal fissure
  • 41. APPROACH TO THE PATIENT • If thickness of fluid greater than 10 mm decubitus radiograph, USG, CT scan, then we should performing diagnostic thoracentesis • In CHF diagnostic thoracentesis is performed if 1The effusion are not bilateral 2. Patient has pleuritic chest pain 3. Patient is febrile
  • 42.
  • 43. APPEARANCE OF PLEURAL FLUID • Bloody- Cancer>PE>Trauma>Pneumonia • Turbid- due to cells or debris or a high lipid level- Empyema Chylothorax pseudochylothorax • Putrid odour- Anaerobic infection. • Ammonia odour- urinothorax
  • 44. Bloody : Hematocrit compared to the blood : • <1% is not significant • 1-20% indicates either cancer, PE or trauma • >50% indicates hemothorax. Centrifuging turbid or milky pleural fluid will distinguish between empyema and lipid effusions. • If the supernatant is clear then the turbid fluid was due to empyema • If it is still turbid -chylothorax OR -pseudochylothorax - Check TG - >110mg/dl – chylothorax If TG<50mg/dl and cholesterol>250 - pseudochylothorax
  • 45.
  • 46. PARAPNEUMONIC EFFUSION AND EMPYEMA • Any pleural effusion associated with bacterial pneumonia ,lung abscess, or bronchiectasis is a parapneumonic effusion • An empyema is pus in pleural space • Complicated parapneumonic effusion-refer to those effusion that do not resolve without therapeutic thoracentesis or tube thoracostomy
  • 47. Bad prognostic factor for parapneumonic effusion and empyema 1Pus present in pleural space 2. Gram stain of pleural fluid is positive 3. Pleural fluid glucose below 40mg/dl 4. Pleural fluid culture positive 5. Pleural fluid ph<7 6. Pleural fluid LDH >3times upper normal limit for serum 7. Pleural fluid loculated These factors indicating likely need for a procedure more invasive than a
  • 48.
  • 49.
  • 50.
  • 51. Pleural effusion related to metastatic malignancies • 2nd most common cause of exudative pleural effusion after parapneumonic effusion • Leading cause of exudative pleural effusion to thoracentesis • Common causes of malignant pleural effusion 1.Lung carcinoma 2. Breast carcinoma 3. Lymphoma and leukemia 4. Ovarian carcinoma 5. sarcoma
  • 52. Pleural fluid in malignant pleural effusion • Almost exudative • Most pleural effusion that meet exudative criteria by the LDH but not by protein level are malignant pleural • bloody pleural effusion • Low pleural glucose level in malignant pleural effusion indicates high tumor burden in pleural space • Approx. one third of patient with malignant disease have a low PH level. low pleural PH also tend to have a low pleural glucose level. they have greater tumor burden, are more likely to have positive pleural fluid cytology and pleural biopsy.
  • 53. Diagnosis of malignant pleural effusion • Cytology- is a fast, efficient, and minimally invasive establishes the diagnosis in more than 70 percent of of metastatic adenocarcinoma less efficient in the diagnosis of a mesothelioma squamous cell carcinoma, lymphoma or a sarcoma. • Immunohistochemical tests-metastatic adenocarcinoma tend to stain positive with CEA,MOC31,BG8,TTF1. malignant mesothelial cells and benign mesothelial cells stain positive with calretinin,keratin5/6,podoplanin,wt1.
  • 54. • Tumor markers in pleural fluid-CEA,CA,NSE,SCC antigen, cytokeratin 19 fragment, • Blood marker of mesothelioma-soluble mesothelin related protien(smrp),osteopontin,megakaryocye potentiating factor(MPF) • If cytology is negative – go for thoracoscopy